Meet Our Professionals >
How did an interest in healthcare policy lead Robert Platt to a career in the law? Find out more>
Search our Experience
Envision to Sell to KKR for $9.9 Billion
We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more
Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.
Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.
Click here to download the guide.
Blogs are a great format to provide updates and perspectives on specific topics. Our blogs are designed to showcase thought leadership by our attorneys related to recent case rulings, laws and ideas related to particular legal areas.
Government Contracts & International Trade
Bass, Berry & Sims Government Contracts & International Trade blog features news, commentary and insight on the demanding and ever-changing regulatory environment of contracting with federal, state and local governments, and international trade issues when conducting a global business.
Read our GovConTrade blog
HR Law Talk
Bass Berry & Sims HR Law Talk blog features news, commentary and insights on the complicated and constantly changing labor and employment laws affecting employers.
Read our HR Law Talk blog
Inside the FCA
Bass, Berry & Sims Inside the FCA features news, commentary and thought leadership related to the False Claims Act, healthcare fraud and procurement fraud issues.
Read our Inside the FCA blog
Securities Law Exchange
Bass, Berry & Sims' Securities Law Exchange blog features commentary and practical insight on SEC updates for publicly traded companies.
Read our Securities Law Exchange blog
Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.